Previous close | 34.87 |
Open | 35.39 |
Bid | 35.48 x 100 |
Ask | 35.74 x 100 |
Day's range | 34.90 - 35.94 |
52-week range | 20.84 - 35.94 |
Volume | |
Avg. volume | 1,107,993 |
Market cap | 3.706B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 33.90 |
EPS (TTM) | 1.05 |
Earnings date | 29 July 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 49.70 |
MENLO PARK, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on July 29, 2024. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in number, and a
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Cool Company (CLCO), Corcept Therapeutics (CORT), TXO Partners (TXO), & JOYY (YY) are well-poised to gain.
ADMA Biologics, American Superconductor, biote, Lincoln Educational Services and Corcept Therapeutics have been highlighted in this Screen of The Week article.